Efficacy of granulocytapheresis and leukocytapheresis for the treatment of microscopic polyangiitis

Therapeutic Apheresis and Dialysis

Volumn 8, Issue 3, 2004, Pages 212-216

  Hasegawa, Midori ^a   Kawamura, Nahoko ^a   Murase, Masamitsu ^a   Koide, Shigehisa ^a   Kushimoto, Hiroko ^a   Murakami, Kazutaka ^a   Tomita, Makoto ^a   Hiki, Yoshiyuki ^a   Shikano, Masahiko ^a   Sugiyama, Satoshi ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Glomerulonephritis; Granulocytapheresis; Leukocytapheresis; Lung Hemorrhage; Microscopic Polyangiitis

Indexed keywords

CORTICOSTEROID; PREDNISOLONE;

ADULT; AGED; CLINICAL ARTICLE; CONFERENCE PAPER; CREATININE BLOOD LEVEL; CYTAPHERESIS; FEMALE; GLOMERULONEPHRITIS; GRANULOCYTAPHERESIS; HUMAN; KIDNEY FUNCTION; LEUKOCYTAPHERESIS; LUNG HEMORRHAGE; MALE; MICROSCOPIC POLYANGIITIS; MULTIPLE DRUG DOSE; PRIORITY JOURNAL; TREATMENT OUTCOME; VASCULITIS;

AGED; CYTAPHERESIS; FEMALE; GLOMERULONEPHRITIS; GRANULOCYTES; HEMORRHAGE; HUMANS; LEUKAPHERESIS; LUNG; MALE; MIDDLE AGED; TREATMENT OUTCOME; VASCULITIS;

EID: 3142545665     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1526-0968.2004.00131.x     Document Type: Conference Paper

References (9)

1. Harper J, Savage CO. Pathogenesis of ANCA-associated systemic vasculitis. J Pathol 2000;190:349-59.
2. Jenette JC, Falk RJ. Antineutrophil cytoplasmic autoantibodies and associated disease: a review. Am J Kidney Dis 1990;14:517-29.
3. Muller Kobold AC, Mesander G, Stegeman CA, Kallenberg CGM, Cohen JW. Are circulating neutrophils intravascularly activated in patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides? Clin Exp Immunol 1998;114:491-9.
4. Kashiwagi N, Sugimura K, Koiwai H et al. Immunomodulatory effects of granulocyte and monocyte adsorption apheresis as a treatment for patients with ulcerative colitis. Dig Dis Sci 2002;47:1334-41.
5. Saniabadi AR, Hanai H, Takeuchi K et al. Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory disease associated with leukocytes. Ther Apher Dial 2003;7(1):48-59.
6. Guillevin L, Lhote F. Treatment of polyarteritis nodosa and microscopic polyangiitis. Arthritis Rheum 1998;41:2100-5.
7. Westman KWA, Bygren PG, Olsson H, Ranstam J, Wieslander J. Relapse rate, renal survival, and cancer morbidity in patients with Wegener's granulomatosis or microscopic polyangiitis with renal involvement. J Am Soc Nephrol 1988;9:842-52.
8. Booth AD, Almond MK, Burns A et al. The Pan-Thames Renal Research Group. Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study. Am J Kidney Dis 2003;41:776-84.
9. Lauque D, Cadranel J, Lazor R et al. GERM"O"P. Microscopic polyangiitis with alveolar hemorrhage: a study of 29 cases and review of the literature. Medicine (Baltimore) 2000;79:222-33.